Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC
Rate of event - free survival higher with neoadjuvant pembrolizumab plus chemo versus chemo alone for early triple - negative breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy